According to Pharming Group's latest financial reports the company has $0.19 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.20 B | -4.61% |
2021-12-31 | $0.21 B | -13.87% |
2020-12-31 | $0.25 B | 202.98% |
2019-12-31 | $83.28 M | -20.75% |
2018-12-31 | $0.10 B | 24.4% |
2017-12-31 | $84.47 M | 139.29% |
2016-12-31 | $35.3 M | -6.67% |
2015-12-31 | $37.82 M | -25.18% |
2014-12-31 | $50.55 M | 56.24% |
2013-12-31 | $32.35 M | 250.78% |
2012-12-31 | $9.22 M | 45.39% |
2011-12-31 | $6.34 M | -65.19% |
2010-12-31 | $18.22 M | -44.24% |
2009-12-31 | $32.68 M | -54.61% |
2008-12-31 | $72 M | -48.04% |
2007-12-31 | $0.13 B | 204.52% |
2006-12-31 | $45.5 M | 124.96% |
2005-12-31 | $20.22 M |